Litcius/Paper detail

Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial

Mehmet Asım Bilen, BaoHan T. Vo, Yuan Liu, Rachel Greenwald, Amir H. Davarpanah, Donald J. McGuire, Rakesh Shiradkar, Liping Li, Adhishek Midya, Bassel Nazha, Jacqueline T. Brown, Sierra Williams, Wilena Session, Greta Russler, Sarah Caulfield, Shreyas Joshi, Vikram M. Narayan, Christopher P. Filson, Kenneth Ogan, Ömer Küçük, Bradley Curtis Carthon, Luke del Balzo, Athena Cohen, Adriana Boyanton, Nataliya Prokhnevska, Maria A. Cardenas, Ewelina Sobierajska, Caroline S. Jansen, Dattatraya Patil, Edouard Nicaise, Adeboye O. Osunkoya, Haydn Kissick, Viraj A. Master

2025Nature Cancer12 citationsDOI

Topics & Concepts

CabozantinibMedicineOncologyRenal cell carcinomaInternal medicineUrologyRenal cell carcinoma treatmentRenal and related cancersPancreatic and Hepatic Oncology Research
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial | Litcius